USPTO 2015–2025 USPTO PatentsView US Corporation

Devicor Medical Products, Inc.

USPTO PatentsView assignee record - 181 granted patents across 21 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

181

Total patents granted

CPC technology areas

15.6

Avg claims per patent

-38%

5-year filing velocity

The verdict

Devicor holds 181 US patents across 21 technology areas, rank #2,172 of 50,000 tracked assignees.

#2,172
of 50,000 US assignees by volume: Top 20%
by Innovation Score (46.8/100): 15.6
avg claims per patent: -38%
filing velocity, last 5 yrs

Portfolio overview

Devicor Medical Products, Inc. has been granted 181 US utility patents between 2015 and 2025, placing Devicor Medical Products, Inc. at rank #2,172 across all assignees tracked by PlainPatent. This portfolio spans 21 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.6 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Devicor Medical Products, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Devicor sits between Pall Corporation (182 patents, rank #2,168) and The Sherwin-williams Company (181 patents, rank #2,176) - the closest US assignees by grant volume. The composite Innovation Score of 46.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 69 grants, compared with 112 in the 2015–2019 window, a -38% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Devicor Medical Products, Inc.'s 15.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 21 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Devicor Medical Products, Inc. against peers pursuing similar technology classes.

Pall

182
TPK Touch Solutio…

182
Toshiba Global Co…

182
Zhejiang Geely Ho…

182
Enphase Energy

181
Mentor Acquisitio…

181
Piaggio & C SPA

181
The Sherwin-willi…

181
Devicor Medical P… ◀

181

What this shows Devicor holds 181 patents at rank #2,172, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Devicor

By rank, the assignees closest to #2,172 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Devicor's primary technology class.

Devicor's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

47 Top 20% higher than 80% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Devicor Medical Products, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	18	9.9%
2016	31	17.1%
2017	23	12.7%
2018	19	10.5%
2019	21	11.6%
2020	12	6.6%
2021	23	12.7%
2022	11	6.1%
2023	7	3.9%
2024	10	5.5%
2025	6	3.3%

Which technologies does Devicor Medical Products, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 166

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 15

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 11

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 10

G01T - MEASUREMENT OF NUCLEAR OR X-RADIATION 8

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 6

C08J - WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H 5

G01R - MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES 5

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 5

B01F - MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING 3

A47K - SANITARY EQUIPMENT NOT OTHERWISE PROVIDED FOR ; TOILET ACCESSORIES 3

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 3

B29C - SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING 2

B65D - CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES 2

Top 15 of 21 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#2,172

Across all tracked assignees

Innovation Score

46.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Devicor Medical Products, Inc. hold?

Devicor Medical Products, Inc. holds 181 US granted patents filed between 2015 and 2025, spanning 21 technology areas.

What is Devicor Medical Products, Inc.'s Innovation Score?

Devicor Medical Products, Inc. has an Innovation Score of 46.8 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Devicor Medical Products, Inc. focus on?

Devicor Medical Products, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 166 patents. The company has filed patents in 21 CPC subclasses total.

Is Devicor Medical Products, Inc.'s patent filing rate increasing or decreasing?

Devicor Medical Products, Inc.'s recent filing velocity is -38% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Devicor Medical Products, Inc.'s patents?

Devicor Medical Products, Inc.'s patents average 15.6 claims each. This falls within the standard range, providing solid legal coverage.

How is the Devicor Medical Products, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Devicor's 181 grants land it in the top 20% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Devicor ranks #2,172 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.